Abstract
Background In early December 2019, the first patient with COVID-19 pneumonia was found in Wuhan, Hubei Province, China. Recent studies have suggested the role of primary laboratory tests in addition to clinical symptoms for suspected patients, which play a significant role in the diagnosis of COVID-19. Therefore, the present study was conducted to evaluate laboratory findings in COVID-19 patients.
Data Sources PubMed/Medline, Scopus, EMBASE, Web of Science (ISI), Cochrane Library, Ovid, Science Direct, CINAHL and EBSCO.
Study Selection Cross-sectional of adverse outcomes stratified by the status of ICLs were selected.
Data Extraction The prevalence of available variables for laboratory tests were extracted.
Results Finally, 52 studies involving 5490 patients with COVID-19 entered the meta-analysis process. The prevalence of leukopenia, lymphopenia, elevated c-reactive protein (CRP), elevated erythrocyte sedimentation rate (ESR), elevated serum amyloid A, elevated ferritin was estimated to be 20.9% (95%CI: 17.9-24.3), 51.6% (95%CI: 44.0-59.1), 63.6% (95%CI: 57.0-69.8), 62.5% (95%CI: 50.1-73.5), 63.6% (95%CI: 57.0-69.8), 62.5% (95%CI: 50.1-73.5), 74.7% (95%CI: 50.0-89.7), and 72.6% (95%CI: 58.1-83.5), respectively. The prevalence of elevated interleukin-6 was 59.9% (95%CI: 48.2-70.5), CD3 was 68.3% (95%CI: 50.1-82.2), reduced CD4 was 62.0% (95%CI: 51.1-71.6), reduced CD8 was 42.7% (95%CI: 32.2-53.9). The prevalence of elevated troponin-I was 20.6% (95%CI: 9.0-40.5), elevated creatine kinase-MB (CKMB) was 14.7% (95%CI: 7.1-28.0), elevated brain natriuretic peptide (BNP) was 48.9% (95%CI: 30.4-67.7), elevated blood urea nitrogen was 13.1% (95%CI: 6.6-24.4),, elevated creatinine was 7.2% (95%CI: 4.4-11.8), elevated lactate dehydrogenase (LDH) was 53.1% (95%CI: 43.6-62.4), hyperglycemia was 41.1% (95% CI: 28.2-55.5), elevated total bilirubin was 48.9% (95%CI: 30.4-67.7), reduced albumin was 54.7% (95%CI: 38.1-70.2), reduced pre-albumin was 49.0% (95%CI: 26.6-71.8), and reduced PT was 53.1% (95% CI: 43.6-62.4), and D-dimer was 44.9% (95%CI: 31.0-59.6).
Conclusion This study provides a comprehensive description of laboratory characteristics in patients with COVID-19. The results show that lymphopenia, elevated CRP, elevated ESR, elevated ferritin, elevated serum amyloid A, elevated BNP, reduced albumin, reduced pre-albumin, reduced CD3, reduced CD4, reduced CD8, elevated D-dimer, reduced PT, elevated interleukin-2, elevated interleukin-6, elevated LDH and hyperglycemia are the common findings at the time of admission.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was funded by the Ilam University of Medical sciences. Funder role was only financial support.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Not applicable.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Not applicable.
Abbreviations
- COVID-19
- Coronavirus disease 2019
- ARDS
- Acute respiratory distress syndrome
- SARS-CoV-2
- Severe acute respiratory syndrome coronavirus 2
- SARS-CoV
- Severe acute respiratory syndrome coronavirus
- MERS-COV
- Middle East respiratory syndrome coronavirus
- WHO
- world health organization
- PHEIC
- Public health emergency of international concern
- PRISMA
- Preferred Reporting Items for Systematic Reviews and Meta-analysis
- CI
- Confidence interval
- ICU
- intensive care unit
- NOS
- Newcastle-Ottawa Scale
- CMA
- Comprehensive Meta-Analysis Software
- CRP
- c-reactive protein
- ESR
- erythrocyte sedimentation rate
- PCT
- procalcitonin
- cTnI
- troponin-I
- CKMB
- creatine kinase-MB
- BNP
- brain natriuretic peptide
- BUN
- blood urea nitrogen
- ALT
- alanine aminotransferase
- AST
- aspartate aminotransferase
- LDH
- lactate dehydrogenase
- CPK
- creatine phosphokinase
- PT
- prothrombin time
- PTT
- partial thromboplastin time
- MODS
- multiple organ dysfunction syndrome
- ACE
- Angiotensin converting enzyme
- DPP-IV
- dipeptidyl peptidase IV
- AKI
- acute kidney injury
- DIC
- Disseminated intravascular coagulation
